The rising demand for ketamine, mainly for psychiatric conditions, presents significant challenges regarding the sale and private transport within the United States. Specific federal laws govern such process, necessitating adherence from vendors. Additionally, ensuring customer anonymity through meticulous packaging and compliant delivery systems i